RESPONSIfVE: efficacy and therapeutic response to Procoralan® in the treatment of chronic stable angina pectoris in routine medical practice

Not Applicable

Completed

• Conditions: Chronic stable angina pectoris/cardiology; Circulatory System; Angina pectoris

• Registration Number: ISRCTN73861224
• Lead Sponsor: Servier Deutschland GmbH (Germany)

Brief Summary

2016 results in https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020130/ [Added 11/01/2019]

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-02-15
• Study Completion: 2013-09-30
• Last Update Posted: 11 February 2019

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 2000

Inclusion Criteria

1. Adult patients, either sex, with chronic stable angina pectoris
2. who are to be routinely treated with Procoralan®, regarding the summary of product characteristics, either in combination or not with beta blocker medications.

Exclusion Criteria

All contraindications listed in summary of product characteristics.

Study & Design

• Study Type: Observational
• Study Design: Not specified